Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: researchers  dietary  banned  stimulants  unapproved  pills  recall  medical  multivu  8216951  childhood  cancer  tumor  health  research  hospital  st  jude  medical  overview  multivu  8121952  health  bvi  body  volume  indicator  bmi  research  weight  mayo  clinic  multivu  8093051  webmd  pregnancy  app  technology  stsi  health  care  mothers  babies  medical  multivu  7579757  health  healthcare  disease  rare  day  awareness  medical  hemophilia  research  multivu  8046151  wine  culinary  food  cooking  restaurant  josep  roca  forum  michel  bettane  barcelona  multivu  7948051  water  cotton  crops  industry  water  usage  technologies  clothing  environmental  multivu  7613831  children  cancer  health  research  cause  pediatric  st  jude  hospital  family  germline  mutations  multivu  7692851  research  astro  science  cancer  early  stage  breast  cancer  health  technology  advancement  doctors  multivu  7661231  research  astro  science  cancer  early  stage  breast  cancer  health  technology  advancement  doctors  multivu  7661231  research  astro  science  cancer  early  stage  breast  cancer  health  technology  advancement  doctors  multivu  7661231  technology  history  egyptian  pyramids  exploring  ministry  antiquities  science  ancient  scan  multivu  7671551 
Search // researchers
Results 1-12 of 46 for ' researchers ' (1 seconds)
Researchers at global public health organization NSF International, Harvard Medical School, the United States Department of Defense and the National Institute for Public Health and the Environment in the Netherlands (RIVM) recently identified four unapproved, DMAA-like stimulants in six over-the-counter weight-loss and pre-workout products currently available online. The research was published in the peer-reviewed journal Clinical Toxicology. The potentially harmful compounds – including banned stimulants 1,3-DMAA and 1,3-DMBA as well as octodrine and a newly identified DMAA analog – were not listed as ingredients in the products and may have been disguised as “2-aminoisoheptane” or extract of Aconitum kusnezoffii. These stimulants may cause adverse cardiac events, hemorrhagic strokes or sudden death, especially if taken prior to strenuous exercise or combined with caffeine. Extreme heat and dehydration may also increase the health risks. To view the multimedia release go to: https://www.multivu.com/players/English/8216951-nsf-international-banned-stimulants-2-aminoisoheptane/
Categories // Miscellaneous 
Added: 67 days ago by MultiVuVideos
Runtime: 1m33s | Views: 6 | Comments: 0
Not yet rated
 

 

 

In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community. St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature. “Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.” To view the multimedia release go to: https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
Categories // Miscellaneous 
Added: 137 days ago by MultiVuVideos
Runtime: 1m34s | Views: 2 | Comments: 0
Not yet rated
 

 

 

Today, the newly-developed Body Volume Indicator (BVI)™ was revealed as a modern day measure of body composition and weight distribution following a 10-year collaboration with Mayo Clinic experts who led extensive research on fat distribution, the importance of fat assessment and the limitations of the current standard of Body Mass Index (BMI). In conjunction with the development of BVI, BVI America LLC, a subsidiary of 3D measurement pioneer Select Research, announced the launch of the revolutionary BVI Pro tablet application, which will provide an easily accessible and affordable means for the professional community to use the new BVI measurement in everyday clinical use to assess health risks. The potential benefits of using Body Volume as a new indicator of risks were presented on April 27 by Mayo Clinic researchers, BVI America and the University of Westminster. It draws on 10 years of rigorous research, testing and validation using several potential Body Volume indices. Now BVI, calculated as a ratio between total volume and abdominal volume, can be used as a supplement to the current measurement standard of BMI, which is based solely on height and weight. BVI is considered to be a more precise means of estimating weight distribution and the fat around the organs, which is not visible to the human eye and can lead to serious health conditions, such as diabetes and heart disease. The medical and professional community at large is invited to contribute to the continued development of BVI by downloading and using the BVI Pro tablet application with their patients and clients; anonymous data collected will be analyzed by Mayo Clinic, whose research and validation of BVI will continue. To view the multimedia release go to: https://www.multivu.com/players/English/8093051-bvi-america-body-volume-app-health-fitness/
Categories // Miscellaneous 
Added: 259 days ago by MultiVuVideos
Runtime: 1m57s | Views: 6 | Comments: 0
Not yet rated
 

 

 

WebMD and Scripps Translational Science Institute (STSI) today announced a new investigative study designed to improve researchers’ and health care professionals’ understanding of what contributes to healthy pregnancies and positive pregnancy outcomes. The Healthy Pregnancy Study will use WebMD’s newly redesigned and enhanced Pregnancy app for iPhone. Incorporation of the Apple ResearchKit software framework will enable survey participants to eConsent, easily and anonymously answer questions, and share connected device data about their pregnancies with researchers for analysis. “Pregnant women are one of the least studied populations in medical research,” said Dr. Eric Topol, director of STSI and editor-in-chief of Medscape. “The results of our Healthy Pregnancy Study -- on the foundation of an exceptionally popular smartphone app -- will ultimately provide expectant mothers, researchers, and health care professionals with new medical insights to avoid complications during pregnancy.” To view the multimedia release go to: https://www.multivu.com/players/English/7579757-webmd-stsi-healthy-pregnancy-study-app/
Categories // Miscellaneous 
Added: 301 days ago by MultiVuVideos
Runtime: 1m16s | Views: 8 | Comments: 0
Not yet rated
 

 

 

Today on Rare Disease Day, My Life, Our Future, a national program founded by leaders in the bleeding disorder community, including Bloodworks Northwest, the American Thrombosis and Hemostasis Network, the National Hemophilia Foundation and Bioverativ Inc., opened the largest research repository of its kind in the world to scientists. The My Life, Our Future Research Repository is a collection of genetic data and blood samples that are linked to phenotypic data from more than 5,000 people in the U.S. with hemophilia, a rare disorder that impairs the ability of one’s blood to clot. The My Life, Our Future Research Repository will allow researchers to advance the scientific understanding of the disorder, including genetic differences that affect bleeding severity and reaction to certain treatments. To view the multimedia release go to: https://www.multivu.com/players/English/8046151-national-hemophilia-foundation-my-life-our-future/
Categories // Miscellaneous 
Added: 321 days ago by MultiVuVideos
Runtime: 1m42s | Views: 8 | Comments: 0
Not yet rated
 

 

 

Barcelona is hosting the third edition of the Wine & Culinary International Forum today, a biennial international conference dedicated to food and wine pairing promoted by Bodegas Torres. Over 250 professionals, including sommeliers, restaurant owners, distributors and journalists from almost 20 different countries, participated in the event. Celebrated in the Palau de Congressos de Catalunya, it provided a forum in which to reflect and discuss the complementary relationship between wine and food under the heading “Wine and World Cuisines.” The president of Bodegas Torres, Miguel A. Torres, opened the event, which featured talks, tastings and culinary demonstrations by a total of 20 national and international experts who are highly regarded in their fields. Among them, Josep Roca, sommelier at El Celler de Can Roca; the award winning wine-writer and journalist Sarah Jane Evans MW, an expert in Spanish wines as well as the former Chairman of the Institute of Masters of Wine; the prestigious French enologist Pascal Chatonnet, one of the leading researchers into the microbiological factors involved in the interaction between wine and oak; Canadian researcher François Chartier, a pioneer in the aromatic science of molecular food matching since 2004 and author of Taste Buds and Molecules, world’s best innovative food 2010; the renowned French wine critic Michel Bettane; and the endocrinologist Dr. Francisco Tinahones, a researcher at the University of Malaga. To view the multimedia release go to: http://www.multivu.com/players/uk/7948051-torres-wine-culinary-international-forum/
Categories // Miscellaneous 
Added: 462 days ago by MultiVuVideos
Runtime: 2m46s | Views: 62 | Comments: 0
Not yet rated
 

 

 

The modern cotton industry has achieved significant environmental gains over the past forty years, but it is not resting on its laurels. Around the world, scientists and researchers strive to develop new ways to grow, process and manufacture cotton more efficiently and with increasingly less impact on the environment. Identifying and implementing new technologies and practices will help the cotton industry meet the current needs for productivity and profit, without compromising the ability of future generations to meet their own needs. Increasingly responsible production and manufacturing are not objectives the cotton industry take lightly. As a natural fiber, the success of cotton is directly linked to the land and its health. Being good stewards of the environment requires continuous attention to reducing impact throughout every link in cotton’s long supply chain—from the seeds from which cotton is grown, to the processing and manufacturing practices of finished cotton goods. To view the multimedia release go to: http://www.multivu.com/players/English/7613831-cotton-sustainability/
Categories // Miscellaneous 
Added: 635 days ago by MultiVuVideos
Runtime: 1m53s | Views: 124 | Comments: 0
Not yet rated
 

 

 

The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer. The study from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project appears in the November 19 edition of the New England Journal of Medicine. Ultimately, researchers anticipate that systematic monitoring of patients and family members who have germline mutations in cancer predisposition genes will allow the detection of cancers at their earliest and most curable stage, thereby improving the outcomes for these children and family members. To view the multimedia release go to: http://www.multivu.com/players/English/7692851-st-jude-hospital-genome-project/
Categories // Miscellaneous 
Added: 788 days ago by MultiVuVideos
Runtime: 2m18s | Views: 159 | Comments: 0
Not yet rated
 

 

 

Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated. Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal. “We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.” To view the multimedia release go to: http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Categories // Miscellaneous 
Added: 811 days ago by MultiVuVideos
Runtime: 1m25s | Views: 218 | Comments: 0
Not yet rated
 

 

 

Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated. Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal. “We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.” To view the multimedia release go to: http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Categories // Miscellaneous 
Added: 811 days ago by MultiVuVideos
Runtime: 3m4s | Views: 220 | Comments: 0
Not yet rated
 

 

 

Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated. Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal. “We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.” To view the multimedia release go to: http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Categories // Miscellaneous 
Added: 811 days ago by MultiVuVideos
Runtime: 2m3s | Views: 264 | Comments: 0
Not yet rated
 

 

 

The Egyptian Ministry of Antiquities is pleased to announce the launch of an egyptian – international Project using non-invasive and non-destructive surveying techniques for the scanning of Egyptian Pyramids under the title “ScanPyramids” project. Just because a mystery is 4500 years old doesn’t mean it can’t be solved…” This could be the motto of the exceptional scientific mission launched October 25, 2015, under the authority of the Egyptian Ministry of Antiquities, initiated, designed and coordinated by the Faculty of Engineering of Cairo and the French HIP.Institute (Heritage, Innovation and Preservation). Radiographic muons, aka cosmic particles, infrared thermography, photogrammetry, scanner and 3D reconstruction: the most innovative technologies will be used by researchers of international renown and three major universities: the Faculty of Engineering of Cairo University, Université Laval of Quebec and Nagoya University of Japan. Their goal: to probe the heart of the largest pyramids of Egypt, without drilling the slightest opening. Four millennia after their construction, these ancient giants are far from having yielded their secrets. The first mystery concerns their construction, especially Khufu, the last of the Seven Wonders of the Ancient World still existing: it is still impossible to describe with certainty how this stone monument, the largest ever built by humans, was erected. The “ScanPyramids” project has already been approved by the permanent committee of the Ministry of Antiquities and has obtained all necessary permissions from concerned authorities. With a base of more than 5 hectares, its original height of almost 150 meters and a mass of 5 million tons, how was it possible to construct such a wonder in only 25 years? To view the multimedia release go to: http://www.multivu.com/players/uk/7671551-scanpyramids-project-launch-egyptian/
Categories // Miscellaneous 
Added: 812 days ago by MultiVuVideos
Runtime: 2m6s | Views: 180 | Comments: 0
Not yet rated
 

 

 

Page 1 of 4  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2018 ClipMoon.com. All rights reserved.